Loading organizations...
Loading organizations...

Activate Venture Partners: Early-stage venture capital firm investing in seed and Series A startups focused on digital health and applied technology.
Activate Venture Partners is an early-stage venture capital firm based in New York City and Bethlehem, Pennsylvania, that invests in capital-efficient digital health and applied technology startups. The firm provides seed and Series A equity financing to high-growth business-to-business software, financial technology, and tech-enabled service providers primarily located in the Mid-Atlantic region. Managing over $200 million in assets under management, the firm has backed more than 100 companies and led over 45 exits, including 10 initial public offerings that generated a combined total of more than $10 billion in enterprise value. Its investment portfolio features notable technology and healthcare companies such as Pendo, Definitive Healthcare, Medidata Solutions, Benefix, and Tabula Rasa HealthCare. Activate Venture Partners was officially founded in 2017 by Glen Bressner and Todd Pietri through the strategic combination of their respective legacy venture capital firms.
Key people at Activate Venture Partners.
Key people at Activate Venture Partners.
Activate Venture Partners is an early-stage venture capital firm specializing in high-growth technology companies, with a strong focus on healthcare technology and enterprise software sectors. Their mission centers on partnering with visionary founders to back innovative startups at the seed and early stages, often as the first institutional investor, providing both capital (typically under $5 million initially) and strategic support to help scale businesses effectively. The firm’s investment philosophy emphasizes founder-focus, deep domain expertise, and hands-on operational guidance, targeting markets at inflection points where technology can disrupt traditional models. Their portfolio includes notable healthcare tech companies like Healthify and Cureatr, reflecting their impact on advancing tech-enabled healthcare solutions and enterprise software innovation[1][2][4].
Founded in 1999 (or 2000, with slight source variation) and originally known as Milestone Venture Partners, Activate Venture Partners was co-founded by Edwin Goodman and Glen Bressner, with key partners including Todd Pietri and Don Yount. The firm evolved from a broader early-stage tech investor to a specialized leader in healthcare and applied technology investments, leveraging decades of experience and a robust network to support startups from their first institutional financing. Their approach is characterized by being founder-centric and offering flexible, on-demand support rather than micromanagement, which has helped them build a portfolio with over 100 investments, 45+ exits, and 10 successful IPOs[1][2][3][6].
Activate Venture Partners rides the wave of digital transformation in healthcare and enterprise software, sectors undergoing rapid innovation due to technological advances and shifting market demands. Their timing is critical as healthcare increasingly integrates AI, data analytics, and cloud computing to improve outcomes and efficiency. By backing startups at early stages, Activate helps shape emerging technologies that address systemic challenges in healthcare delivery and enterprise operations. Their influence extends beyond capital, fostering ecosystems that accelerate innovation adoption and disrupt legacy systems, contributing to broader trends like healthtech democratization and enterprise digitalization[1][2][4].
Looking ahead, Activate Venture Partners is well-positioned to capitalize on continued growth in tech-enabled healthcare and applied technology sectors, especially as AI and data-driven solutions become more central to these industries. Their founder-focused, flexible support model will likely attract visionary entrepreneurs aiming to tackle complex healthcare and enterprise challenges. Trends such as personalized medicine, telehealth expansion, and cloud-native enterprise solutions will shape their investment focus. As the firm continues to leverage its deep domain expertise and network, its influence on the startup ecosystem and technology innovation is expected to grow, reinforcing its role as a key early-stage investor driving impactful technological change[2][6].